Edition:
United States

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

9.91USD
26 Apr 2018
Change (% chg)

-- (--)
Prev Close
$9.91
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,592
52-wk High
$18.17
52-wk Low
$9.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.312
Jun '17 0.00 -1.488
FY 2016 Dec '16 0.00 -0.302
Sep '16 0.00 -0.516
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.37 0.50 0.20 --
Year Ending Dec-19 3 23.08 26.00 20.44 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.62 -0.58 -0.65 --
Quarter Ending Sep-18 3 -0.95 -0.72 -1.36 --
Year Ending Dec-18 3 -2.77 -2.67 -2.96 --
Year Ending Dec-19 3 -2.16 -1.77 -2.39 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.19 32.74
P/E High - Last 5 Yrs. -- 40.82 45.72
P/E Low - Last 5 Yrs. -- 20.23 24.22
Beta -- 0.79 0.88
Price to Sales (TTM) -- 7.40 5.71
Price to Book (MRQ) -- 13.07 5.37
Price to Tangible Book (MRQ) -- 26.47 6.95
Price to Cash Flow (TTM) -- 21.76 23.32
% Owned Institutions -- 4.99 2.17

Dividends

  Company industry sector
Dividend Yield -- 1.03 1.50
Dividend Yield - 5 Year Avg -- 1.20 1.51
Dividend 5 Year Growth Rate -- 16.81 5.32
Payout Ratio(TTM) -- 30.00 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.43 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 2.03 5.69
Sales - 5 Yr. Growth Rate -- 8.75 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 48.75 19.36
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 19.27 10.76
Capital Spending - 5 Yr. Growth Rate -- 8.67 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.19
Current Ratio (MRQ) -- 3.13 2.98
LT Debt to Equity (MRQ) -- 30.29 12.18
Total Debt to Equity (MRQ) -- 36.88 16.45
Interest Coverage (TTM) -- 16.02 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.82 54.44
Gross Margin - 5 Yr. Avg. -- 58.59 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 23.26 10.96
Operating Margin (TTM) -- 17.75 4.73
Operating Margin - 5 Yr. Avg. -- 16.02 6.40
Pre-Tax Margin (TTM) -- 17.48 5.57
Pre-Tax Margin - 5 Yr. Avg. -- 16.25 6.81
Net Profit Margin (TTM) -- 13.43 1.87
Net Profit Margin - 5 Yr. Avg. -- 11.35 3.09
Effective Tax Rate (TTM) -- 22.58 23.04
Effective Tax Rate - 5 Yr. Avg. -- 28.85 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 26,739,010 846,829,796
Net Income/Employee (TTM) -- 3,194,059 99,616,056
Receivable Turnover (TTM) -- 5.08 5.78
Inventory Turnover (TTM) -- 3.15 3.35
Asset Turnover (TTM) -- 0.77 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.45 10.95
Return on Assets - 5 Yr. Avg. -- 9.08 12.31
Return on Investment (TTM) -- 13.89 14.38
Return on Investment - 5 Yr. Avg. -- 11.76 16.10
Return on Equity (TTM) -- 16.72 16.07
Return on Equity - 5 Yr. Avg. -- 14.17 17.39

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.13%
# of Holders: 36
Total Shares Held: 14,480,612
3 Mo. Net Change: 236,449
# New Positions: 10
# Closed Positions: 1
# Increased Positions: 10
# Reduced Positions: 1
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.